Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Inventory Average (2022 - 2025)

Arcutis Biotherapeutics has reported Inventory Average over the past 4 years, most recently at $22.5 million for Q4 2025.

  • For Q4 2025, Inventory Average rose 57.85% year-over-year to $22.5 million; the TTM value through Dec 2025 reached $22.5 million, up 57.85%, while the annual FY2025 figure was $18.6 million, 34.35% up from the prior year.
  • Inventory Average for Q4 2025 was $22.5 million at Arcutis Biotherapeutics, up from $19.4 million in the prior quarter.
  • Over five years, Inventory Average peaked at $22.5 million in Q4 2025 and troughed at $5.9 million in Q4 2022.
  • A 4-year average of $13.7 million and a median of $13.6 million in 2024 define the central range for Inventory Average.
  • Biggest five-year swings in Inventory Average: soared 128.8% in 2023 and later rose 5.52% in 2024.
  • Year by year, Inventory Average stood at $5.9 million in 2022, then soared by 128.8% to $13.5 million in 2023, then increased by 5.52% to $14.3 million in 2024, then surged by 57.85% to $22.5 million in 2025.
  • Business Quant data shows Inventory Average for ARQT at $22.5 million in Q4 2025, $19.4 million in Q3 2025, and $16.5 million in Q2 2025.